Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy

Background: In the current Japanese aging society, a high number of very elderly patients (age ranged from 80 to 93) with diffuse large B-cell lymphoma (DLBCL, most frequent hematological malignancy), who require chemotherapy are encountered. However, standard chemotherapy can result in severe adver...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Hiroto Kaneko, Kazuho Shimura, Mihoko Yoshida, Yosuke Matsumoto, Tsutomu Kobayashi, Hitoji Uchiyama, Junya Kuroda, Masafumi Taniwaki
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Tehran University of Medical Sciences 2022-01-01
Reeks:	International Journal of Hematology-Oncology and Stem Cell Research
Onderwerpen:	Diffuse large B-cell lymphoma; Elderly; Rituximab combined cyclophosphamide; Doxorubicin; Vincristine and prednisolone (R-CHOP); Albumin
Online toegang:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1316
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!